Abstract A043: Allele Specific Characteristics of KRAS Q61 Mutated Gastrointestinal Malignancies with Clinical Outcomes and Transcriptomic Features in Pancreatic Cancer
Pan-RAS and allele-specific inhibitors are entering clinical practice. Understanding KRAS-specific features is vital for therapy and overcoming resistance. We examined clinical and molecular traits of KRASQ61-mutated gastrointestinal cancers, especially pancreatic. Using Palantir Foundry, we queried surviv...